Blaise Lippa
Chief Tech/Sci/R&D Officer at MORPHIC HOLDING, INC.
Profile
Blaise Lippa is currently the Chief Scientific Officer at Morphic Therapeutic, Inc. since 2015 and at Morphic Holding, Inc. since 2022.
Previously, Blaise worked as the Senior Director-Medicinal Chemistry at Cubist Pharmaceuticals LLC.
Blaise holds a doctorate degree from Stanford University and an undergraduate degree from the University of Michigan.
Blaise Lippa active positions
Companies | Position | Start |
---|---|---|
MORPHIC HOLDING, INC. | Chief Tech/Sci/R&D Officer | 11/05/2022 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 31/05/2015 |
Former positions of Blaise Lippa
Companies | Position | End |
---|---|---|
CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Training of Blaise Lippa
Stanford University | Doctorate Degree |
University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MORPHIC HOLDING, INC. | Health Technology |
Private companies | 2 |
---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Blaise Lippa